Anthony M. Manning insider trades: Monte Rosa Therapeutics (GLUE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anthony reports to the SEC
Open-market buys and sales
36 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | GLUE | ↓ Sell | 10,000 | $18.01 | $180K | Direct | May 22, 2026 (1d) |
| Aug 13, 2020 | MNTA | ↓ Sell | 403 | $29.31 | $12K | Direct | Aug 13, 2020 (0d) |
| Aug 10, 2020 | MNTA | ↓ Sell | 347 | $32.36 | $11K | Direct | Aug 11, 2020 (1d) |
| Jul 21, 2020 | MNTA | ↓ Sell | 1,939 | $34.69 | $67K | Direct | Jul 23, 2020 (2d) |
| Jul 20, 2020 | MNTA | ↓ Sell | 51,099 | $33.91 | $1.7M | Direct | Jul 21, 2020 (1d) |
| Jun 30, 2020 | MNTA | ↓ Sell | 6,811 | $35.10 | $239K | Direct | Jul 1, 2020 (1d) |
| Jun 12, 2020 | MNTA | ↓ Sell | 6,756 | $30.15 | $204K | Direct | Jun 15, 2020 (3d) |
| May 11, 2020 | MNTA | ↓ Sell | 414 | $33.75 | $14K | Direct | May 12, 2020 (1d) |
| May 8, 2020 | MNTA | ↓ Sell | 336 | $33.30 | $11K | Direct | May 11, 2020 (3d) |
| Apr 21, 2020 | MNTA | ↓ Sell | 1,886 | $30.55 | $58K | Direct | Apr 22, 2020 (1d) |
| Apr 20, 2020 | MNTA | ↓ Sell | 1,614 | $28.96 | $47K | Direct | Apr 21, 2020 (1d) |
| Mar 6, 2020 | MNTA | ↓ Sell | 7,310 | $29.00 | $212K | Direct | Mar 9, 2020 (3d) |
| Feb 18, 2020 | MNTA | ↓ Sell | 16,459 | $32.56 | $536K | Direct | Feb 20, 2020 (2d) |
| Feb 13, 2020 | MNTA | ↓ Sell | 9,330 | $30.17 | $281K | Direct | Feb 14, 2020 (1d) |
| Feb 11, 2020 | MNTA | ↓ Sell | 112 | $32.23 | $4K | Direct | Feb 12, 2020 (1d) |
| Feb 10, 2020 | MNTA | ↓ Sell | 224 | $31.50 | $7K | Direct | Feb 11, 2020 (1d) |
| Jan 22, 2020 | MNTA | ↓ Sell | 2,265 | $29.01 | $66K | Direct | Jan 24, 2020 (2d) |
| Jan 21, 2020 | MNTA | ↓ Sell | 1,235 | $30.08 | $37K | Direct | Jan 22, 2020 (1d) |
| Jan 15, 2020 | MNTA | ↓ Sell | 29,114 | $28.44 | $828K | Direct | Jan 17, 2020 (2d) |
| Dec 24, 2019 | MNTA | ↓ Sell | 51,445 | $20.00 | $1.0M | Direct | Dec 27, 2019 (3d) |
| Nov 13, 2019 | MNTA | ↓ Sell | 619 | $16.53 | $10K | Direct | Nov 14, 2019 (1d) |
| Nov 12, 2019 | MNTA | ↓ Sell | 169 | $16.18 | $3K | Direct | Nov 13, 2019 (1d) |
| Nov 8, 2019 | MNTA | ↓ Sell | 8,757 | $15.96 | $140K | Direct | Nov 12, 2019 (4d) |
| Oct 18, 2019 | MNTA | ↓ Sell | 6,365 | $13.83 | $88K | Direct | Oct 21, 2019 (3d) |
| Oct 14, 2019 | MNTA | ↓ Sell | 787 | $13.55 | $11K | Direct | Oct 16, 2019 (2d) |
| Aug 12, 2019 | MNTA | ↓ Sell | 114 | $11.64 | $1K | Direct | Aug 13, 2019 (1d) |
| Aug 8, 2019 | MNTA | ↓ Sell | 221 | $11.82 | $3K | Direct | Aug 9, 2019 (1d) |
| Jun 20, 2019 | MNTA | ↓ Sell | 39,433 | $13.00 | $513K | Direct | Jun 21, 2019 (1d) |
| May 10, 2019 | MNTA | ↓ Sell | 114 | $14.00 | $2K | Direct | May 14, 2019 (4d) |
| May 8, 2019 | MNTA | ↓ Sell | 224 | $13.68 | $3K | Direct | May 9, 2019 (1d) |
| Feb 14, 2019 | MNTA | ↓ Sell | 4,449 | $13.10 | $58K | Direct | Feb 19, 2019 (5d) |
| Feb 13, 2019 | MNTA | ↓ Sell | 7,717 | $12.70 | $98K | Direct | Feb 14, 2019 (1d) |
| Feb 12, 2019 | MNTA | ↓ Sell | 133 | $12.77 | $2K | Direct | Feb 13, 2019 (1d) |
| Feb 8, 2019 | MNTA | ↓ Sell | 264 | $11.52 | $3K | Direct | Feb 11, 2019 (3d) |
| Nov 12, 2018 | MNTA | ↓ Sell | 113 | $13.15 | $1K | Direct | Nov 14, 2018 (2d) |
| Nov 8, 2018 | MNTA | ↓ Sell | 229 | $14.09 | $3K | Direct | Nov 13, 2018 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GLUE insiders
Open-market trades in the last 12 months
About Anthony M. Manning's insider trades
Anthony M. Manning is an insider at Monte Rosa Therapeutics (GLUE). Since Nov 8, 2018, Anthony has reported no open-market purchases and 36 sales worth $6.5M on SEC Form 4. In the last 12 months: 1 sale ($180K).
Their filings also include grants and awards (19 filings), option exercises (17 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GLUE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.